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ABSTRACT
Purpose: To determine the local government area (LGA)-level prevalence of trachoma in all 34
LGAs of Katsina State.
Methods: A population-based prevalence survey was conducted in each LGA of Katsina State,
using the Global Trachoma Mapping Project methodology. We used a 3-stage cluster random
sampling strategy to select 25 households from each of 25 clusters. We examined all residents of
selected households aged 1 year and older for the clinical signs of trachomatous inflammation–
follicular (TF), trachomatous inflammation–intense and trichiasis, using the World Health
Organization (WHO) simplified grading scheme.
Results: We examined 129,281 persons. Six LGAs had a TF prevalence ≥10%, and another six LGAs
had a TF prevalence between 5% and 9.9%; all 12 require mass drug administration with
azithromycin plus other interventions. The prevalence of trichiasis was ≥1.0% in 13 LGAs, and
there is a need to perform trichiasis surgery in over 26,000 persons to reach targets set by the
WHO for elimination of trichiasis.
Conclusion: The prevalence of TF is generally low in Katsina state, but urgent steps must be taken to
implement the full SAFE strategy (surgery, antibiotics, facial cleanliness, environmental improve-
ment) in at least 12 LGAs while also stepping up efforts to provide community-based trichiasis
surgery throughout the whole state, in order to make trachoma elimination by 2020 a reality.
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Introduction
Trachoma, caused by Chlamydia trachomatis, is spread by
direct contact with ocular and nasal discharges from
infected persons, by contact with fomites, and by eye-
seeking muscid flies. Recurrent infections can result in
scarring of the conjunctivae and inward turning of the
eyelashes, which scratch the eyeball. This condition,
referred to as trachomatous trichiasis, is painful and
when untreated may lead to trachomatous corneal opaci-
fication, an irreversible cause of visual impairment.
Blindness from trachoma can be avoided by implemen-
tation of the SAFE strategy (surgery for trichiasis, antibio-
tics to clear infection, and promotion of facial cleanliness
and environmental improvement to reduce transmission).
The SAFE strategy is recommended by the World Health
Organization (WHO)1 for elimination of trachoma as a
public health problem.2 Considerable successes have been
reported with this strategy.3–6
In Katsina State, Nigeria, trachoma was last docu-
mented about 10 years ago7,8 in 10 local government
areas (LGAs). Those data suggested that five LGAs
required at least three years’ implementation of the
full SAFE strategy and the other five required at least
1 year’s implementation.8 LGAs are the normal admin-
istrative units for health care management in Nigeria,
and therefore the appropriate choice as the local
equivalent of the WHO-defined “district” for trachoma
elimination.9,10 However, LGA-level prevalence data
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have not been available for the whole state, and as a
result, the SAFE strategy has not yet been fully
deployed in Katsina State.
This work aimed to provide the data required for
planning SAFE strategy implementation throughout
Katsina State, by conducting a population-based tra-
choma prevalence survey in each of the state’s 34 LGAs.
Materials and methods
Sample size calculation, pre-survey field team training
and certification, and data collection techniques all fol-
lowed the standard Global Trachoma Mapping Project
(GTMP) protocols, as described elsewhere.11 LGAs were
used as evaluation units. We selected 25 clusters of 25
households in each LGA, expecting to find a mean of just
over two children aged 1–9 years per household. This put
1250 children in the sampling frame per LGA. Allowing
for 20% non-response, we anticipated being able to recruit
the minimum sample size of 1019 children aged 1–9 years
in each LGA using this approach.
Ethics
Protocols were approved by the Ethics Committee of the
London School of Hygiene & Tropical Medicine (reference
6319), the National Health Research Ethics Committee of
Nigeria (reference NHREC/01/01/2007), and the Katsina
State Ministry of Health ethics subcommittee. The Katsina
State Ministry of Health also gave administrative permis-
sion to conduct the surveys. Field teams explained the
examination protocol to each adult in a language they
understood. Since most study subjects could neither read
nor write, only verbal consent for enrolment and examina-
tion was obtained. The head of the household gave consent
for the participation of minors and adults gave consent for
their own participation. Consent was documented in an
Open Data Kit-based Android smartphone application
(LINKS)11 by research teams. Individuals with active tra-
choma were given two tubes of 1% tetracycline eye oint-
ment together with instructions for its use, and persons
with trichiasis were referred for lid surgery at the nearest
facility with trained trichiasis surgeons.
Sampling
We used a 3-stage cluster sampling strategy to select the
survey population in each LGA. Villages (with popula-
tions between 13,000 and 16,000 people) were used as first
stage clusters and 25 villages were selected from a list of all
the villages in each LGA, using a probability-propor-
tional-to-size technique. Each selected village’s (pre-exist-
ing) administrative units, which were of approximately
equal size (mean 4500 people), were listed, and one of
these units was selected at random. In selected units, 25
households were required, with a household defined as all
the individuals normally resident in the compound eating
from the same pot. All persons older than 1 year of age in
selected households were invited to participate. Because
security in northern Nigeria was somewhat tenuous at the
time of survey planning and implementation, use of a
household selection method already familiar to the popu-
lation was felt to be critical to field team safety, so the
random walk approach was used despite its epidemiolo-
gical drawbacks.12–14 A person resident in the village
showed the survey team the center of the administrative
unit. A pen was spun on the ground at that point and the
direction the pen pointed was followed, with households
in this direction being selected. Field teamsmade an effort
to return on the same day and examine persons that were
absent at the first visit.
Survey definitions
We used the WHO simplified grading scheme.15 Teams
examined participants for the presence of trachomatous
inflammation–follicular (TF), trachomatous inflamma-
tion–intense, and trichiasis. In eyes with trichiasis, we did
not record the presence or absence of trachomatous con-
junctival scarring, so in this manuscript we are only able to
talk about trichiasis, rather than trachomatous trichiasis.
We have reported the prevalence of TF in 1–9-year-olds
and the prevalence of trichiasis in persons aged 15 years
and older as our primary outcome measures for disease
elimination planning purposes. Data on household-level
access to water and sanitation were collected using stan-
dard GTMP protocols.11
Data analysis
As described previously, data were cleaned by the GTMP
data manager (RW) and analyzed using pre-specified algo-
rithms to control for age and sex of those recruited, and
the number of individuals examined in each cluster11. The
trichiasis backlog in each LGA was calculated by multi-
plying the prevalence estimate in persons aged 15 years
and older by 56% of the total population in the LGA (as
determined in the most recent census), because 56% of the
Nigerian population is 15 years and older.16
Results
We examined a total of 129,281 persons in Katsina
State between March and June 2014. The ages of parti-
cipants ranged from 1 year to over 100 years. More
females (69,961; 54.1%) were examined than males
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(59,320; 45.9%). The age and sex distributions of parti-
cipants for the state as a whole are shown in Table 1.
A total of 59,971 children aged 1–9 years were
examined; 30,351 (50.6%) were male and 29,620
(49.4%) were female. State-wide, the prevalence of TF
in this age group was 4.9% (95% confidence interval,
CI, 4.7–5.1%). The prevalence in girls (4.8%, 95% CI
4.6–5.1%) was lower than in boys (4.9%, 95% CI 4.7–
5.2%), but there was no statistically significant differ-
ence in TF prevalence between the sexes (odds ratio,
OR, 1.02, 95% CI 0.95–1.10; χ2 = 0.41, p = 0.52). The
LGA-level age-adjusted prevalences of TF in 1–9-year-
olds ranged from 0.0–29.5% (Table 2, Figure 1).
We examined 56,156 persons aged 15 years and
older; 22,607 (40.3%) were male and 33,549 (59.7%)
were female. The state-wide prevalence of trichiasis
was 1.8% (95% CI 1.7–1.9%) in this age group. The
trichiasis prevalence in adult females (2.1%, 95% CI
1.9–2.2%) was greater than in adult males (1.4%, 95%
CI 1.3–1.6%), this difference was statistically significant,
with an OR of 1.4 (95% CI 1.1–1.6; χ2 = 37.5, p =
0.0005). The LGA-level age- and sex-adjusted preva-
lences of trichiasis in adults ranged from 0.0–3.6%
(Table 2, Figure 2).
Six LGAs (Bakori, Batsari, Dutsi, Funtua, Ingawa,
and Mashi) in Katsina State had TF prevalences
≥10%, with another six LGAs (Jibia, Kafur, Kaita,
Kankara, Mani, and Sabuwa) had TF prevalences
between 5% and 9.9%. The prevalence of trichiasis
was ≥1% in 13 LGAs (Batagarawa, Batsari, Baure,
Daura, Dutsi, Ingawa, Kaita, Kusada, Mai’ Adua,
Mashi, Safana, Sandamu, and Zango). Given the esti-
mated population of Katsina State is 5,801,584,16 there
is therefore an estimated trichiasis backlog of 32,335
persons; ignoring incident trichiasis, 26,258 people
need to be offered trichiasis surgery to achieve the
trichiasis prevalence criterion for elimination of tra-
choma as a public health problem17 in every Katsina
State LGA (Table 3).
Across LGAs, the proportion of households that had
access to water for hygiene purposes within 1 km of the
location of the house ranged from 24% to 100%.
Similarly, proximate access to improved water for
hygiene purposes was as low as 10% in three LGAs.
Over 80% of households had proximate access to
improved washing water in only two LGAs. Access to
improved latrines ranged from 1% to 100%, but only
four of the 34 LGAs had >80% access to improved
latrines (Table 4).
Various aspects of the SAFE strategy will need to be
implemented in each LGA to be able to attain the
elimination thresholds recommended by WHO
(Table 5).
Discussion
In Katsina State, trachoma is still a public health pro-
blem. Bakori, Batsari, Dutsi, Funtua, Ingawa and Mashi
LGAs had TF prevalences in 1–9-year-olds between
10% and 29.9%, and therefore qualify for azithromycin
mass drug administration (MDA) plus implementation
of the F and E components of the SAFE strategy, for an
initial period of 3 years, as recommended by WHO.10
Another six LGAs had TF prevalences between 5% and
Table 1. Age and sex distribution of participants, Global
Trachoma Mapping Project, Katsina State, Nigeria, 2014.
Age group
(years) Female, n (%) Male, n (%) Total, n (%)
1–10 31,835 (49.3) 32,685 (50.7) 64,520 (49.9)
11–20 9,961 (59.1) 6900 (40.9) 16,861 (13.0)
21–30 10,852 (76.9) 3261 (23.1) 14,113 (10.9)
31–40 7766 (64.6) 4256 (35.4) 12,022 (9.3)
41–50 4631 (50.0) 4638 (50.0) 9269 (7.2)
51–60 2598 (41.2) 3710 (58.8) 6308 (4.9)
61–70 1496 (37.8) 2465 (62.2) 3961 (3.1)
71–80 637 (37.3) 1071 (62.7) 1708 (1.3)
81+ 185 (35.6) 334 (64.4) 519 (0.4)
Total 69,961 (54.1) 59,320 (45.9) 129,281 (100.0)
Table 2. Local government area (LGA)-level prevalence of tra-
chomatous inflammation–follicular (TF) and trichiasis, Global
Trachoma Mapping Project, Katsina State, Nigeria, 2014.
LGA
Age-adjusted TF
prevalence in 1–9-year-
olds, % (95% CI)
Age- and sex-adjusted trichiasis
prevalence in those ≥15 years,
% (95% CI)
Bakori 29.5 (25.5–34.6) 0.0 (0.0–0.0)
Batagarawa 4.7 (3.5–6.2) 1.7 (1.1–2.4)
Batsari 13.5 (7.6–18.9) 1.7 (1.1–2.2)
Baure 0.0 (0.0–0.0) 3.6 (2.6–4.6)
Bindawa 4.4 (3.5–5.6) 0.3 (0.1–0.5)
Charanchi 0.1 (0.0–0.4) 0.2 (0.1–0.3)
Dan Musa 3.2 (2.5–3.9) 0.4 (0.1–0.7)
Dandume 1.6 (0.6–3.3) 0.3 (0.1–0.6)
Danja 3.1 (1.9–4.2) 0.3 (0.1–0.6)
Daura 2.4 (1.5–3.4) 2.7 (1.5–4.4)
Dutsi 11.3 (8.7–13.6) 1.9 (1.0–2.9)
Dutsin Ma 1.5 (0.6–2.7) 0.7 (0.4–1.0)
Faskari 1.1 (0.5–1.8) 0.0 (0.0–0.0)
Funtua 10.7 (7.0–15.5) 0.2 (0.1–0.4)
Ingawa 12.2 (8.2–17.2) 1.4 (0.9–1.9)
Jibia 5.1 (4.0–6.5) 0.6 (0.4–0.9)
Kafur 7.0 (5.4–8.6) 0.2 (0.1–0.4)
Kaita 9.8 (6.4–13.6) 1.1 (0.5–1.8)
Kankara 6.3 (4.4–8.0) 0.7 (0.3–1.2)
Kankia 4.2 (2.7–6.2) 0.7 (0.2–1.2)
Katsina 4.4 (3.3–5.7) 0.3 (0.1–0.5)
Kurfi 3.3 (1.8–4.8) 0.4 (0.2–0.5)
Kusada 0.9 (0.6–1.3) 1.0 (0.5–1.7)
Mai’Adua 4.5 (3.0–6.5) 3.0 (1.8–4.6)
Malumfashi 0.5 (0.1–0.9) 0.3 (0.0–0.9)
Mani 8.1 (6.5–9.9) 0.3 (0.1–0.6)
Mashi 15.4 (10.9–21.5) 1.2 (0.7–1.8)
Matazu 0.1 (0.0–0.2) 0.6 (0.2–1.1)
Musawa 1.5 (0.1–4.1) 0.3 (0.2–0.4)
Rimi 0.2 (0.0–0.4) 0.2 (0.1–0.3)
Sabuwa 9.6 (6.8–12.4) 0.5 (0.3–0.9)
Safana 1.4 (0.9–2.0) 1.7 (1.1–2.2)
Sandamu 2.4 (0.9–4.2) 1.6 (0.8–2.3)
Zango 0.4 (0.1–0.6) 2.6 (1.7–3.8)
CI, confidence interval.
OPHTHALMIC EPIDEMIOLOGY 57
9.9% and may benefit from at least one round of MDA
in addition to the F and E components of SAFE.18 All
but two of six LGAs with TF prevalences ≥10% had
<80% household-level access to a proximate washing
water supply, and none had ≥80% household-level
access to improved latrine facilities. Some LGAs had
very low prevalence of access to improved latrines, and
this seemed to mirror higher prevalences of TF. The
proportion of households using improved washing
water in these LGAs was generally extremely low, start-
ing from 9%. Funtua was the exception, with good
reported access to water for washing, but the popula-
tion in this LGA had poor access to improved latrines;
all other LGAs with TF ≥10% also had poor access to
improved latrines. Full implementation of the SAFE
strategy in Katsina State will require a particular focus
on provision of improved water and sanitation facil-
ities. In addition to providing the hardware, commu-
nities will need to be educated on the relationship
between trachoma blindness, and water and sanitation,
with an emphasis on the need for facial cleanliness and
appropriate disposal of solid human waste.
The LGA of Kaita had a relatively low (9.8%) TF
prevalence, indicating the need for intervention with
only one year of MDA, but had a significant trichiasis
burden, with an estimated trichiasis prevalence in
adults of 1.1%. This would be consistent with the view
that trachoma is disappearing from this LGA, as
Figure 1. Prevalence of active trachoma (trachomatous inflammation–follicular, TF) in 1–9-years-olds in Katsina State, Nigeria, 2014.
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previously suggested.7 In two previous surveys, Kaita
was found to have a high prevalence of both TF and
trichiasis.7,8
A total of 10 LGAs in Katsina State participated in
population-based trachoma prevalence surveys in 2005,
using comparable methodologies to those outlined
here.7 For five of those 10, the results of the current
round of surveys are similar to those obtained in 2005.
For Baure, Kaita, Mai Adua, and Zango, however, the
2005 work suggested that three or more rounds of
azithromycin MDA was needed, while the current
data indicate that either a single round should be
attempted (Kaita) or that (for the other four LGAs),
implementation of the A, F and E components of SAFE
is not a priority. Access to water and sanitation facilities
has remained essentially the same in these LGAs in the
10-year interval between surveys, and trachoma elim-
ination interventions have not been undertaken. We
therefore attribute the apparent falls in the prevalence
of TF to general socioeconomic development, or
changes in population dynamics. Part of the rationale
for repeating the prevalence estimates in already-sur-
veyed areas of Katsina was the impression within gov-
ernment that living conditions have improved, and that
therefore the scale of interventions against trachoma
required could be smaller than might have been
Figure 2. Prevalence of trichiasis in ≥15-year-olds in Katsina State, Nigeria, 2014.
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previously planned. Those suspicions about the reduc-
tion in the prevalence of TF and the scale of interven-
tions required appear to have been borne out.
Katsina State has a trichiasis backlog of over 31,000
people needing surgery. Trichiasis prevalence is >1% in
adults in 13 LGAs (Batagarawa, Batsari, Baure, Daura,
Dutsi, Ingawa, Kaita, Kusada, Mai’ Adua, Mashi, Safana,
Sandamu, and Zango). Ignoring incident trichiasis, over
26,000 individuals will need to be offered trichiasis surgery
in Katsina State in order to eliminate trachoma throughout
the state. With only seven active trichiasis surgeons living
in the state, this presents a considerable challenge. There is
clearly a need for more trained surgeons; this should be
achieved through an organized local training and certifica-
tion program for active eye nurses.19 Once trained, there is
a need to ensure that each nurse is properly equipped,
incentivized, deployed and supervised. Katsina State will
require at least 15 lid surgeons performing at least 10
trichiasis surgeries weekly to be able to attain the elimina-
tion target for trichiasis by the year 2020 or earlier. In
rolling out a trichiasis program in Katsina State, priority
needs to be given to Baure, Daura, Mai’Adua, and Zango
LGAs, where the prevalence of trichiasis is higher com-
pared to the other LGAs.
For the SAFE strategy to succeed in Katsina State,
expansion of trichiasis surgery services, rapid imple-
mentation of high coverage azithromycin MDA, and
provision and appropriate use of sanitation and water
services, are required. Early and robust engagement
with water and sanitation agencies will be critical, as
well as focused efforts to incorporate education on
trachoma and its prevention within existing health
education campaigns. With less than 5 years to go
before the target date for global elimination of tra-
choma as a public health problem, this work cannot
begin too soon.
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Table 3. Local government area (LGA)-level estimates of trichia-
sis surgery backlog, Global Trachoma Mapping Project, Katsina
State, Nigeria, 2014.
LGA
Estimated
total
population
Trichiasis
prevalence in
persons aged
≥15 years, %
Estimated
trichiasis
backlog, n
People to be
offered trichiasis
surgery to achieve
the trichiasis
component of
“elimination of
trachoma as a
public health
problem”, n
Bakori 149,516 0.0 0 0
Batagarawa 189,059 1.7 1849 1637
Batsari 207,874 1.7 2003 1770
Baure 202,941 3.6 4038 3811
Bindawa 151,002 0.3 245 76
Charanchi 136,989 0.2 122 0
Dan Musa 113,190 0.4 229 102
Dandume 145,323 0.3 226 63
Danja 125,481 0.3 195 54
Daura 224,884 2.7 3448 3196
Dutsi 120,902 1.9 1266 1131
Dutsin Ma 169,829 0.7 671 481
Faskari 194,400 0.0 9 0
Funtua 225,156 0.2 250 0
Ingawa 169,148 1.4 1297 1107
Jibia 167,435 0.6 572 384
Kafur 209,360 0.2 264 30
Kaita 182,405 1.1 1073 868
Kankara 243,259 0.7 905 632
Kankia 151,395 0.7 609 440
Katsina 318,132 0.3 604 247
Kurfi 116,700 0.4 241 110
Kusada 98,348 1.0 546 435
Mai’Adua 201,800 3.0 3373 3147
Malumfashi 182,891 0.3 354 149
Mani 176,301 0.3 301 104
Mashi 171,070 1.2 1156 965
Matazu 113,814 0.6 371 243
Musawa 170,006 0.3 294 103
Rimi 154,092 0.2 161 0
Sabuwa 140,679 0.5 428 271
Safana 185,207 1.7 1756 1549
Sandamu 136,944 1.6 1189 1036
Zango 156,052 2.6 2291 2117
Total 5,801,584 32,335 26,258
Table 4. Household access to wash water and improved
latrines, Global Trachoma Mapping Project, Katsina State,
Nigeria, 2014.
LGA
Wash water
access <1 km, %
Improved wash water
access <1 km, %
Improved
latrine access,
%
Bakori 69.2 43.0 34.3
Batagarawa 93.1 33.9 41.0
Batsari 51.6 31.9 18.0
Baure 39.0 48.1 30.1
Bindawa 71.0 46.5 10.4
Charanchi 65.7 45.7 9.8
Dan Musa 98.1 11.2 9.8
Dandume 99.5 33.9 64.6
Danja 73.7 50.7 55.5
Daura 71.5 10.8 71.9
Dutsi 52.4 10.4 57.1
Dutsin Ma 76.4 53.8 29.4
Faskari 65.3 26.9 30.1
Funtua 100.0 96.4 44.5
Ingawa 49.9 33.0 29.1
Jibia 80.2 30.1 27.7
Kafur 86.9 29.6 100.0
Kaita 49.2 61.2 9.7
Kankara 82.7 35.6 95.0
Kankia 49.1 48.1 16.7
Katsina 95.3 18.1 88.7
Kurfi 52.4 46.9 16.1
Kusada 66.7 71.5 21.3
Mai’Adua 24.0 28.6 34.4
Malumfashi 93.9 57.0 47.8
Mani 43.3 50.6 25.0
Mashi 83.8 17.4 15.0
Matazu 62.6 62.8 25.6
Musawa 65.3 60.2 28.0
Rimi 67.8 57.1 42.4
Sabuwa 95.8 95.8 1.4
Safana 65.9 38.3 11.3
Sandamu 66.0 10.2 65.0
Zango 49.8 49.8 81.6
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